Sodium hypochlorite is one of 30 small molecule programs targeting Infection. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
40 competitors in Randomized
Rayos
Tricor
Yondelis
Precedex
Methylthioninium Chloride
Rituxan
Zytiga
Erleada
Jaypirca
Casodex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details